Article
Noninvasive fetal RHD genotyping to guide targeted anti‐D prophylaxis–an external quality assessment workshop
4 Mar 2019
Abstract excerpt
BACKGROUND AND OBJECTIVES: Fetal RHD genotyping of cell-free fetal DNA from RhD-negative pregnant women can be used to guide targeted antenatal and postnatal anti-D prophylaxis for the prevention of RhD immunization. To assure the quality of clinical testing, we conducted an external quality assessment workshop with the participation of 28 laboratories. MATERIALS AND METHODS: Aliquots of pooled maternal plasma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
